Geode Therapeutics Inc.
1 clinical trials · Sponsor
◉ Watch Geode Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC) (NCT06866795) | Geode Therapeutics Inc. | 2025-07-01 |
Track Geode Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.